Cardiology Wiki
Search
Ctrl
+
K
Cardiology Wiki
Search
Ctrl
+
K
wiki
concepts
AAV Gene Delivery
ACHD Anatomic–Physiologic (AP) Classification
Acute Limb Ischemia (ALI)
AHA/ACC Acute PE Clinical Categories (2026)
Adverse Pregnancy Outcomes
AF-CARE Framework
AF Staging
AI in Cardio-Oncology
Alcoholic Cardiomyopathy
Amiodarone-Induced Thyroid Disorders
Amiodarone Pulmonary Toxicity
Ankle-Brachial Index (ABI)
Aortic Regurgitation
Aortic Stenosis
Arrhythmogenic Cardiomyopathy (ACM)
ARVC Task Force Criteria (2010 Modified)
ASCVD Risk Assessment
Atrial Cardiomyopathy
Atrial Failure
Atrial Myopathy in HCM
Autonomic Dysfunction in Cancer
Balloon Pulmonary Angioplasty (BPA)
Bidirectional Ventricular Tachycardia
Biological Pacemaker
Blood Culture–Negative Endocarditis (BCNE)
Calcium Homeostasis in HCM
Complementary and Alternative Medicine in Heart Failure
Cancer-Associated Arrhythmia
Cancer-Associated VTE
Cancer Therapy-Related Cardiovascular Toxicity (CTR-CVT)
Cardiac Action Potential
Cardiac Amyloidosis — Multimodality Imaging
Cardiac Rehabilitation
Cardiac Repolarization
Cardio-Obstetrics
Cardio-Oncology
Cardiogenetic Centers
Cardiorenal Syndrome
Cascade Family Screening (ACM & HCM)
Catheter Ablation for Atrial Fibrillation
Calcific Aortic Valve Disease — Molecular Mechanisms
CHA2DS2-VA Score
Circadian Rhythm and Cardiac Electrophysiology
ClinGen Gene-Disease Validity Framework
Clonal Hematopoiesis
Chronic Limb-Threatening Ischemia (CLTI)
Conduction Disorders in Young Adults
Conduction System Pacing
Constrictive Pericarditis vs Restrictive Cardiomyopathy
Coronary Microvascular Dysfunction
Coronary Vasospasm
CRISPR-Cas9 in Channelopathies
Cuffless Blood Pressure Monitoring
DAPT Strategies in ACS and CCD
Desmosome (Cardiac)
Diuretic Resistance
Drug-Induced Arrhythmia
Direct-to-Consumer Genetic Testing (DTC-GT)
Dyslipidemia Management
Early-Onset Atrial Fibrillation
Eisenmenger Syndrome
Electrical Remodeling
Electrical Storm
Epicardial Adipose Tissue Arrhythmogenesis
Epigenetics of Cardiac Arrhythmia
Exercise and Sports Participation in HCM
Exercise Restriction in ARVC
Fabry Cardiomyopathy
Familial Hypercholesterolemia
Final Common Pathway (Cardiomyopathy)
Fontan Circulation — Adult Management
Gene Editing Risk-Benefit Framework
Gene Silencing Therapy
Genetic Testing in Atrial Fibrillation
Genetic Testing in Cardiomyopathy
Gut Microbiome in Heart Failure
GWAS in Cardiac Genetics
HCM Risk-SCD (and HCM Risk-Kids)
Heart-Healthy Dietary Patterns
Heart Valve Centre
Heteroplasmy
HFA-ICOS Cardiovascular Toxicity Risk Stratification
Heart Failure with Preserved Ejection Fraction (HFpEF)
His Bundle Pacing
Hormonal Therapy Cardiovascular Risk
Hyperacute T-waves
Hypertensive Disorders of Pregnancy
Incidental Cardiovascular Genetic Variants
Infective Endocarditis
Ion Channel Mutations
Ion Channel Remodeling in HCM
iPSC-Derived Cardiomyocytes
Late Gadolinium Enhancement (LGE)
Left Bundle Branch Area Pacing
Left Cardiac Sympathetic Denervation
Life's Essential 8
Lipoprotein(a)
Long Noncoding RNA in CVD
LQTS Pregnancy Management
LV Diastolic Function
Left Ventricular Outflow Tract Obstruction (LVOTO)
MEPPC (Multifocal Ectopic Premature Purkinje-Related Complexes)
MINOCA
Mitochondrial Cardiomyopathy
Mitral Stenosis
Modifier Genes
Myocardial Viability
Noncoding RNA in Cardiovascular Disease
Obesity Paradox
OMI/NOMI Paradigm
OSA Arrhythmogenic Substrate
PAH Risk Stratification
Perioperative Cardiovascular Assessment
Periprocedural CIED Management
Pharmacogenomics in Heart Failure
Pharmacological Provocation Testing
Phenotypic Approach to Cardiomyopathy
Polygenic Risk Score
Preeclampsia
Prepregnancy Cardiovascular Health
Primary Mitral Regurgitation
Pulsed-Field Ablation
PVC-Induced Cardiomyopathy
PVC Mapping and Ablation
Q-Wave Remodeling
Renal Denervation
Right Heart Catheterization
RV–PA Coupling
Schwartz Score
Secondary Mitral Regurgitation
Septal Reduction Therapy (SRT)
Shanghai Score System
Sleep-Disordered Breathing
Sports Cardiology and Shared Decision-Making
ST-T Changes
Structural Valve Deterioration
Subclinical Atrial Fibrillation (SCAF)
Sudden Cardiac Death
Suppression-and-Replacement (SupRep) Therapy
TAVI (Transcatheter Aortic Valve Implantation)
Tetralogy of Fallot (Repaired) — Adult Management
Titin Isoform Switch
Titin Post-Translational Modifications (PTMs)
Torsades de Pointes
Tricuspid Regurgitation
VA Risk Stratification in Dilated Cardiomyopathy
Valvular Heart Disease
Genetic Variant Reclassification in Cardiovascular Disease
Visceral Adiposity and Ectopic Fat
entities
Acute Coronary Syndrome
Arrhythmogenic Left Ventricular Cardiomyopathy (ALVC)
Amiodarone
Andersen-Tawil Syndrome (LQT7)
Anderson-Fabry Disease (AFD)
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Atrial Fibrillation
Atrial Flutter
Transthyretin Amyloidosis (ATTR)
Bicuspid Aortic Valve
Brugada Syndrome
Chronic Coronary Disease
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Dilated Cardiomyopathy (DCM)
DES (Desmin)
Dronedarone
DSC2 (Desmocollin-2)
DSG2 (Desmoglein-2)
DSP (Desmoplakin)
Early Repolarization Syndrome
Fabry Disease
Flecainide
FLNC (Filamin-C)
Hypertrophic Cardiomyopathy (HCM)
Heart Failure
Hypertension
Idiopathic Ventricular Fibrillation
Ischemic Stroke
JUP (Plakoglobin) — Naxos Disease
KCNH2 (hERG)
KCNJ2 (Kir2.1)
KCNQ1
LMNA (Lamin A/C)
Long QT Syndrome
Maternal Health Disparities
Mavacamten
Mitral Valve Prolapse
MYBPC3 (Cardiac Myosin Binding Protein C)
MYH6 (Alpha-Myosin Heavy Chain)
MYH7 (Beta-Myosin Heavy Chain)
Non-Dilated Left Ventricular Cardiomyopathy (NDLVC)
NOS1AP
Obesity
Obstructive Sleep Apnea
Peripartum Cardiomyopathy
Peripheral Artery Disease
PKP2 (Plakophilin-2)
PLN (Phospholamban)
PMCardio Queen of Hearts
PRKAG2 Cardiac Syndrome
Pulmonary Embolism
Pulmonary Hypertension
Restrictive Cardiomyopathy (RCM)
Rheumatic Heart Disease
RYR2
SCN5A
Short QT Syndrome
TMEM43
TTN (Titin)
sources
AAV-mediated gene therapy for cardiac tachyarrhythmia: A systematic review and meta-analysis
2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management
2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
2024 ESC Guidelines for the Management of Atrial Fibrillation
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association
2026 AHA/ASA Guideline for Early Management of Acute Ischemic Stroke
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association
Amiodarone: A Comprehensive Guide for Clinicians
Amiodarone Pulmonary Toxicity
Amiodarone: Review of Pulmonary Effects and Toxicity
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology
Cardiac arrhythmias and genetics – current stage
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC
Blood Culture–Negative Endocarditis: A Scientific Statement From the American Heart Association
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk
Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Brugada Syndrome (State-of-the-Art Review)
Catheter Ablation for Atrial Fibrillation: Indications and Future Perspective
Core Components of Cardiac Rehabilitation Programs: 2024 Update
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
2022 ESC Guidelines on Cardio-Oncology
Cardio-Oncology: Vascular and Metabolic Perspectives — AHA Scientific Statement 2019
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies — AHA Scientific Statement 2019
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association
Cardiac Channelopathies: Clinical Diagnosis and Promising Therapeutics
Circadian Influences on Sudden Cardiac Death and Cardiac Electrophysiology
ClinGen Curation Activity Summary Report 2026-05-09
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature
Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association
EHRA Clinical Consensus Statement on Conduction System Pacing Implantation (2023)
Cardiac Conduction System Pacing: A Comprehensive Update
Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association
Cardiovascular Considerations in Caring for Pregnant Patients
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
2026 AHA Dietary Guidance to Improve Cardiovascular Health
Dronedarone
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4)
Recommendations for the Evaluation of LV Diastolic Function by Echocardiography and for HFpEF Diagnosis: An Update from the ASE (2025)
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes
Early-onset atrial fibrillation without structural heart disease: lifestyle and hereditary risk factors
Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue
2023 ESC Guidelines for the Management of Cardiomyopathies
Anderson–Fabry Disease Management: Role of the Cardiologist
Fabry Disease Cardiomyopathy: A State-of-the-Art Review
Failure of standard contemporary STEMI ECG criteria to identify acute LAD occlusion
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
Gene editing for inherited cardiac conditions: A new frontier in cardiology
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications
Clinical Genetic Testing for Atrial Fibrillation: Are We There Yet?
Genetically based atrial fibrillation: Current considerations for diagnosis and management
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Genetic testing in early-onset atrial fibrillation
Genetic Testing for Inherited Cardiovascular Diseases — AHA Scientific Statement 2020
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease
The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies
Hyperacute T Waves Are Specific for Occlusion Myocardial Infarction, Even Without Diagnostic ST-Segment Elevation
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association
2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System
2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 2
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis — Part 1
Cardiovascular Imaging in Contemporary Cardio-Oncology: A Scientific Statement From the American Heart Association
State of the Art: Imaging for Myocardial Viability — AHA Scientific Statement
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart Association
2026 ACC/AHA Guideline on the Management of Dyslipidemia
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for ASCVD — AHA Scientific Statement 2021
Long QT Syndrome Management during and after Pregnancy
Cardiac Transmembrane Ion Channels and Action Potentials: Cellular Physiology and Arrhythmogenic Behavior
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease
Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association
Modifier Genes for Sudden Cardiac Death
Cardiac Myosin-Binding Protein C (MYBPC3) in Cardiac Pathophysiology
Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3 and MYH7-Mediated Hypertrophic Cardiomyopathy
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review
2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association
The Diagnostic Role of Pharmacological Provocation Testing in Cardiac Electrophysiology — EHRA Consensus 2025
2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
Precision therapy in congenital long QT syndrome
Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart Association
Mapping and Ablation of Premature Ventricular Complexes
2024 ACC/AHA Guideline for the Management of Lower Extremity Peripheral Artery Disease
Electrocardiographic Q-Wave 'Remodeling' in Reperfused ST-Segment Elevation Myocardial Infarction: Validation Study With CMR
Cardiac Repolarization in Health and Disease
Right heart catheterization in heart failure: indications, interpretation, and pitfalls
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association
RYR2 Variants in Catecholaminergic Polymorphic Ventricular Tachycardia Patients: Insights From Protein Structure and Clinical Data
Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications — AHA Scientific Statement
Electrophysiological Mechanisms of ST Segment and T‑Wave Changes: Insights into Ischemia, Conduction Delay, Hypertrophy, and Electrolyte Disturbance
Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap — AHA Scientific Statement 2019
Titin (TTN): from molecule to modifications, mechanics, and medical significance
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association
Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association
Source Index
Wiki Index
Arrhythmia index
Cardiology Wiki
Enter your search text in the box above
Select a result to preview
#fabry-disease
Fabry Disease
See
entities/Anderson-Fabry-Disease
for the full entity page.